Welcome to the DZIF -
the German Center for Infection Research

Community-Acquired Infections at Mucosal Interfaces

Hepatitis

HIV

Infections of the Immunocompromised Host

Healthcare-Associated Infections

Malaria and Neglected Tropical Diseases

Emerging Infections

Novel Antibiotics

Tuberculosis

Sep 10 2024

INCATE marks its third anniversary of successfully supporting innovators fighting antimicrobial resistance

Aug 28 2024

Open Day at the Science Campus Braunschweig-Süd on 21 September 2024

On Saturday, 21 September 2024, the Helmholtz Centre for Infection Research (HZI), together with the German Center for Infection Research (DZIF) and other research institutions, invites the interested

Close up view of the injection of a vaccine through a syringe into the arm of a person wearing a mask.

Aug 20 2024

New vector vaccine against COVID-19 provides long-term protection

The protective effect of established vaccines is initially very robust, but wanes relatively quickly. This limitation imposes a need for periodic booster shots, which drives

Blood-sucking mosquito whose proboscis has pierced the skin, with a red-coloured abdomen.

Aug 6 2024

Very slow developing malaria pathogens could be suitable as a vaccine

Scientists from the Heidelberg Medical Faculty at Heidelberg University, the Centre for Infectious Diseases at Heidelberg University Hospital and the German Center for Infection Research have

Aug 5 2024

The DZIF at the 25th International AIDS Conference "AIDS 2024" in Munich

The 25th International Conference took place in Munich from 22 to 26 July. More than 10,000 guests from all over the world gathered in Munich. The five-day meeting brought together people living

All news

DZIF promotes podcast:

Infektiopod

Listen in: In each episode, a team of three consisting of initiator Dr Till Koch, Dr Annette Hennigs and Dr Elena Terhalle discuss specific diseases and current research findings. The current 86th issue deals, among other things, with multi-resistant gram-negative pathogens and treatment options for resistance.

More information about the podcast

Cut-out from the cover of the 2022 annual report

pdf (3.36 MB)

DZIF Annual Report 2022

pdf (3.36 MB)

Video

Das zentrale Bioprobenregister im DZIF

Video

pdf (3.65 MB)

DZIF Annual Report 2021

pdf (3.65 MB)

Find Media Content

Hamburg - Lübeck - Borstel - Riems

Clinical Tuberculosis Centre

The Clinical Tuberculosis Centre provides the expertise and infrastructure for the optimisation, prevention, diagnosis and treatment of tuberculosis (TB) as well as for translating research results into clinical practice. The main objectives of the Clinical Tuberculosis Centre include coordinating clinical research activities involving the DZIF TB cohort. This cohort includes [...]

Hannover - Braunschweig | Heidelberg | München | Tübingen

Transplant Cohort

Medical data and biological samples obtained from transplant patients are collected and managed across Germany with the help of the DZIF Transplant Cohort. The data and samples form the basis of scientific studies which investigate the connections between numerous factors influencing an organ’s susceptibility to infection and organ function. In [...]

Hannover - Braunschweig

Preclinical development of Amidochelocardins

The challenge of antibiotic drug development today is the discovery and optimisation of novel bioactive compounds that do not show cross-resistances with clinically applied antibiotics, ideally due to a novel mode of action (MoA) which adresses unexploited microbial targets. In the case of chelocardin, this antibiotic substance was identified several [...]

Tübingen

New strategies for specific eradication of Staphylococcus aureus

In this project, the scientists develop genetically engineered phage lysins and specific bacteriocins for the elimination of hospital germs such as Staphylococcus aureus, they clarify mechanisms of potential resistance mechanisms, and they analyse whether broad-spectrum or specifically acting agents have a more effective and lasting effect on colonization by [...]